Literature DB >> 20799243

Cognitive dysfunction in patients with type 2 diabetes.

Yael D Reijmer1, Esther van den Berg, Carla Ruis, L Jaap Kappelle, Geert Jan Biessels.   

Abstract

People with diabetes mellitus are at increased risk of cognitive dysfunction and dementia. This review explores the nature and severity of cognitive changes in patients with type 2 diabetes. Possible risk factors such as hypo- and hyperglycemia, vascular risk factors, micro- and macrovascular complications, depression and genetic factors will be examined, as well as findings from brain imaging and autopsy studies. We will show that type 2 diabetes is associated with modest cognitive decrements in non-demented patients that evolve only slowly over time, but also with an increased risk of more severe cognitive deficits and dementia. There is a dissociation between these two 'types' of cognitive dysfunction with regard to affected age groups and course of development. Therefore, we hypothesize that the mild and severe cognitive deficits observed in patients with type 2 diabetes reflect separate processes, possibly with different risk factors and aetiologies.

Entities:  

Mesh:

Year:  2010        PMID: 20799243     DOI: 10.1002/dmrr.1112

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  87 in total

Review 1.  Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.

Authors:  Masatsugu Horiuchi; Masaki Mogi
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

2.  Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes.

Authors:  Laura M Raffield; Gretchen A Brenes; Amanda J Cox; Barry I Freedman; Christina E Hugenschmidt; Fang-Chi Hsu; Jianzhao Xu; Benjamin C Wagner; Jeff D Williamson; Joseph A Maldjian; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2015-09-25       Impact factor: 2.852

3.  Increased resting state functional irregularity of T2DM brains with high HbA1c: sign for impaired verbal memory function?

Authors:  Xin Zhang; Ying Yu; Zhe-Sheng Shi; Ke Xu; Jia-Hao Feng; Ze-Yang Li; Xiang-Nan Zhang; Shu-Ning Shen; Yang Yang; Lin-Feng Yan; Jin Zhang; Qian Sun; Bo Hu; Guang-Bin Cui; Wen Wang
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

4.  The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study.

Authors:  Andreea M Rawlings; A Richey Sharrett; Marilyn S Albert; Josef Coresh; B Gwen Windham; Melinda C Power; David S Knopman; Keenan Walker; Sheila Burgard; Thomas H Mosley; Rebecca F Gottesman; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2019-05-21       Impact factor: 19.112

Review 5.  Astrocytic energetics during excitatory neurotransmission: What are contributions of glutamate oxidation and glycolysis?

Authors:  Gerald A Dienel
Journal:  Neurochem Int       Date:  2013-07-06       Impact factor: 3.921

6.  Diabetes is associated with lower global cognitive function in schizophrenia.

Authors:  Yoichiro Takayanagi; Nicola G Cascella; Akira Sawa; William W Eaton
Journal:  Schizophr Res       Date:  2012-09-29       Impact factor: 4.939

7.  Gallic acid modulates cerebral oxidative stress conditions and activities of enzyme-dependent signaling systems in streptozotocin-treated rats.

Authors:  I J Kade; J B T Rocha
Journal:  Neurochem Res       Date:  2013-02-05       Impact factor: 3.996

8.  Diabetes and the elderly brain: sweet memories?

Authors:  Katherine Samaras; Perminder S Sachdev
Journal:  Ther Adv Endocrinol Metab       Date:  2012-12       Impact factor: 3.565

9.  A link between type 2 diabetes and brain function.

Authors:  Christina E Hugenschmidt
Journal:  JAAPA       Date:  2013-12

Review 10.  Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

Authors:  Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs
Journal:  J Int Neuropsychol Soc       Date:  2014-02-20       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.